UiPath 10-Q Confirms Q2 Profitability; CEO Dines Adopts Plan to Sell Up to 5M Shares
PATH sits 52% above its 52-week low of $9.2.
Summary
UiPath's 10-Q confirms Q2 FY27 profitability and $1.4B in liquidity, but reveals CEO Daniel Dines and three other executives adopted 10b5-1 plans to sell up to 5.8M shares combined through early 2027.
Key Events · Earnings and Guidance · PATH
-
Q2 FY27 Results Confirmed
Revenue of $410.3M (up 13% YoY), GAAP operating income of $31.6M, and net income of $36.1M for the quarter ended July 31, 2026.
-
CEO Dines Adopts 5M Share Sale Plan
On July 15, 2026, IceVulcan Investments (controlled by CEO Daniel Dines) adopted a 10b5-1 plan to sell up to 5,000,000 Class A shares through February 1, 2027.
-
Three Other Executives File Sale Plans
COO Ashim Gupta (480,224 shares), CLO Brad Brubaker (137,020 shares), and CPTO Raghu Malpani (180,087 shares) adopted 10b5-1 plans in June-July 2026.
-
Strong Liquidity Position
Cash, cash equivalents, and marketable securities totaled $1,406.5M as of July 31, 2026, with $162.6M in operating cash flow for the first half.
Analysis · PATH · Technology
The 10-Q confirms the Q2 FY27 results first reported on September 3 — revenue of $410.3M (up 13% YoY), GAAP operating income of $31.6M, and net income of $36.1M. The company holds $1.4B in cash and investments and generated $162.6M in operating cash flow during the first half. The new disclosure that matters most is the insider selling: CEO Daniel Dines, through IceVulcan Investments, adopted a 10b5-1 plan on July 15 to sell up to 5 million shares through February 1, 2027. Combined with plans from COO Ashim Gupta (480,224 shares), CLO Brad Brubaker (137,020 shares), and CPTO Raghu Malpani (180,087 shares), insiders have arranged to sell roughly 5.8 million shares over the next several months. This comes on top of the $23.4M in open-market insider sales already executed over the past 90 days. The company also repurchased $268.5M of its own stock during the half, partially offsetting the insider overhang.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30% of the 1973 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.12%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PATH was trading at $13.98 on NYSE in the Technology sector, with a market capitalization of approximately $7.3B. The 52-week trading range was $9.20 to $19.84. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.